VIDEO

FindCenter AddIcon

Introducing Bia Labate, PhD - Soltara Science & Culture Coordinator

By Bia Labate — 2018

We are pleased and honored to introduce Bia Labate, PhD, to the Soltara advisory team as Science and Culture Coordinator.

08:43 min

01:32:51

Dr. Robin Carhart-Harris: Can Psychedelics Cure Depression?

Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.

Video
Robin Carhart-Harris
2019
FindCenter AddIcon
01:20:04

Paul Stamets at the Psilocybin Summit 2020 - Psilocybin Mushrooms & Their Emergent Medicines

Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.

Video
Paul Stamets
2020
FindCenter AddIcon
10:53

The Impact of Growing Up in a Domination Culture (W/ Riane Eisler)

Riane Eisler joins the Thom Hartmann program, warning that we are in regression and that we can still make progress, if we handle regressions from human rights victories, like the election of Donald Trump.

Video
Riane Eisler
2019
FindCenter AddIcon
03:35

Your Brain on Ayahuasca: The Hallucinogenic Drug

Video
2016
FindCenter AddIcon
27:42

The Shadow Side of Ayahuasca with Rachel Harris

Rachel Harris, PhD, a psychologist, is author of Listening to Ayahuasca: New Hope for Depression, Addictions, PTSD, and Anxiety. Here she discusses some of the potential hazards and dangers associated with the ritual use of ayahuasca.

Video
Jeffrey Mishlove
2017
FindCenter AddIcon
01:03:04

Christopher Timmermann—the Neurophenomenology of the DMT State

The Neurophenomenology of the DMT State, presented by Christopher Timmermann from Imperial College London, UK

Video
2019
FindCenter AddIcon
49:53

How Do Psychedelic Drugs Work on the Brain?

Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.

Video
Robin Carhart-Harris
2013
FindCenter AddIcon
58:45

Robin Carhart-Harris: Brain Imaging Studies with Psilocybin and MDMA

Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.

Video
Robin Carhart-Harris
2013
FindCenter AddIcon
17:18

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

Video
Robin Carhart-Harris
2013
FindCenter AddIcon
24:21

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research

Psychedelics afford a unique opportunity to expand our understanding of consciousness and its altered states, to develop techniques for enhancing consciousness, and to uncover new avenues of treatment and improved therapeutic techniques.

Video
Amanda Feilding
2013
FindCenter AddIcon

EXPLORE TOPIC

Drug Policy